Evolving strategies in the treatment of rheumatoid arthritis: a historical perspective by Julia Domańska-Poboża, Małgorzata Wisłowska

Subjects: Get full text

Asthma and Arthritis: Are there any similarities? by Bhadrish Vallabh, Dhamend Lutchman

Subjects: Get full text

Comparison of Efficacy and Safety of Single Versus Combination Dmard Therapy in Rheumatoid Arthritis-A Prospective Observational Study by Mayank P. Singh, Mukesh K. Sharma, Himanshy Rai, Tribhuwan N. S. Gaur, Vishnu K. Gupta, Ranjeet S. Dohare

Subjects: “…dmard…”
Get full text

Efficacy of iguratimod in the treatment of patients with palindromic rheumatism ineffective to methotrexate or hydroxychloroquine by Mengjie Chen, Yongjun Cheng, Guiyao Jin, Yuren Tu, Qi Zhang, Chuanfu Zhang, Wenlong Wang

Subjects: Get full text

Pharmacological pain management in patients with rheumatoid arthritis: a narrative literature review by Natasha Cox, Christian D. Mallen, Ian C. Scott

Subjects: Get full text

Comparison of seropositive and seronegative rheumatoid arthritis patients using or about to be initiated with biological DMARDS by Zehra Özsoy, Şerife Asya Germe, Gizem Ayan, Güllü Sandal Uzun, Mustafa Ekici, Erdinç Ünaldı, Levent Kılıç, Ali Akdoğan, Şule Apras Bilgen, Sedat Kiraz, Ali İhsan Ertenli

Subjects: Get full text

Secukinumab Persistence in Patients with Psoriatic Arthritis: An Adalimumab-Matched Retrospective Cohort Database Study (FLYWAY) by Hideto Kameda, Kentaro Ishii, Junna Kiriyama, Toshiaki Mikami, Hideya Uratsuji, Akimichi Morita

Subjects: Get full text

Risk of Serious Infections in Patients Treated With Biologic or Targeted‐synthetic Disease Modifying Antirheumatic Drugs in Qatar by Sreethish Sasi, Hamad Abdel Hadi, Masautso Chaponda, Reem El Ajez, Mohamed Ataelmanan, Sief Khasawneh, Hind Saqallah, Maisa Ali, Nabeel Abdulla, Javed Iqbal, Ali S. Omrani, Muna Al Maslamani, Abdullatif Al‐Khal

Subjects: Get full text

Clinical Outcomes of Methotrexate Usage in Postoperative Arthroplasty Patients: An Evidence Based Review by Koppert J, Heikoop D, Lanting BA

Subjects: “…DMARD…”
Get full text

Effectiveness and patient-reported impact of on-flare retreatment in patients with rheumatoid arthritis: insights from retrospective long-term real-world data by Delphine Bertrand, Elias De Meyst, Michaël Doumen, Diederik De Cock, Johan Joly, Barbara Neerinckx, Sofia Pazmino, Nele Pype, Tom Conings, René Westhovens, Patrick Verschueren

Subjects: Get full text

Newly-diagnosed rheumatoid arthritis patients have elevated levels of plasma extracellular vesicles with protein cargo altered towards inflammatory processes by Anne Rydland, Fatima Heinicke, Tuula A. Nyman, Anne-Marie Siebke Trøseid, Siri T. Flåm, Maria Stensland, Johanna Gehin, Joakim Eikeland, Reidun Øvstebø, Maria Dahl Mjaavatten, Benedicte A. Lie

Subjects: Get full text

Retrospective investigation of the results of long-term treatment with disease modifying drugs in rheumatoid arthritis by D Karateev

Subjects: Get full text

Influence of Medication on Flare Up and Infection After Elective Orthopedic Surgery in Rheumatoid Arthritis Patient – A Narrative Review by Yaldi Rosadi, Yustin Marinta, Muthiah Nur Afifah

Subjects: Get full text

Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies by Philip J. Mease, Joseph F. Merola, Yoshiya Tanaka, Laure Gossec, Iain B. McInnes, Christopher T. Ritchlin, Robert B. M. Landewé, Akihiko Asahina, Barbara Ink, Andrea Heinrichs, Rajan Bajracharya, Vishvesh Shende, Jason Coarse, Laura C. Coates

Subjects: Get full text

Leflunomide as an alternative csDMARD for rheumatoid arthritis in a resource-constrained setting: A real-life experience by P E Mkhize, AJ Viljoen

Subjects: Get full text

How has the COVID-19 pandemic affected our rheumatology patients using biological/targeted DMARDs? by Semih Gulle, Yesim Erez, Ali Karakas, Tuba Yuce Inel, Sinem Burcu Kocaer, Tuba Demirci Yildirim, Gercek Can, Ismail Sari, Merih Birlik, Fatos Onen

Subjects: Get full text

Safety of antibodies to measles, mumps, rubella and diphtheria in patients with juvenile idiopathic arthritis by I. V. Fridman, N. A. Lybimova, O. V. Goleva, Yu. E. Konstantinova, M. M. Kostik

Subjects: Get full text

Dual anti-cytokine biologic and/or targeted synthetic therapy combination in spondyloarthritis: a narrative review. Are we missing the opportunity for higher remission rates? by Elsa Vieira-Sousa, Elsa Vieira-Sousa, Pedro Ávila-Ribeiro, Pedro Ávila-Ribeiro, João Eurico Fonseca, João Eurico Fonseca

Subjects: Get full text

2-years outcomes of the treat-to-target strategy in early psoriatic arthritis by E. Yu. Loginova, T. V. Korotaeva, E. E. Gubar, P. O. Tremaskina, S. I. Glukhova, E. L. Nasonov

Subjects: Get full text

Aging does not impact safety and efficacy of biologic or targeted synthetic disease-modifying antirheumatic drugs in patients with rheumatoid arthritis by Yasemin Tombak, Ajda Bal, Emel Eksioglu, Nihan Abidin, Ozgur Zeliha Karaahmet, Deniz Dulgeroglu

Subjects: “…bDMARDs…”
Get full text